ZS Pharma
Coppell
About ZS Pharma
ZS Pharma is a privately held specialty pharmaceutical company based in Coppell, Texas, and Menlo Park, CA. Its core focus is the research and development of highly selective ion-trap therapies to treat serious medical conditions. The company'ss therapeutic candidate, ZS-9, is a novel treatment for hyperkalemia, a life-threatening condition that affects patients with chronic kidney disease, hypertension, diabetes, and/or chronic heart failure. Hyperkalemia is characterized by abnormally high concentrations of potassium in the blood. ZS-9 is currently being tested in late-stage clinical trials.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $128.3M
- Funding stage: M&A
- Last round: Post-IPO Debt (Jul 2014)
- Ticker: nasdaq:ZSPH
- Website: zspharma.com
- Phone: 877-700-0240
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/zs-pharma-1244159 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.